Kelse Patrice Mckinley, MD
Family Practice · Fairfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 10
Offices
10 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Sutter Medical Center, Sacramento · Sutter Solano Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mckinley’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A104778 · Current
Licensed to practise in California · since 2008 · expires 2028-04-30 · Tulane University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Solano Medical CenterVallejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Solano Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.6 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.36 (106.6 to 218.11) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 65 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,268 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,327 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.7 (0.38 to 5.03) · 594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 285 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.78) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.1 (0 to 16.32) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.77 (3.74 to 11.8) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.48) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 171 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.8 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 162 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 160 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.5) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.8 to 14.4) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.6 to 18.9) · 322 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.6) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (355 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$39,601
Medicare paid this office $39,601 for 330 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 213 | $22,380 | $100 |
| Short return visit (20+ min) | 64 | $4,424 | $64 |
| New patient visit (45+ min) | 27 | $3,362 | $125 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 16 | $2,236 | $140 |
| New patient visit (30+ min) | 17 | $1,538 | $90 |
See all 8 services
| Return visit (30+ min) | 213 | $22,380 | $100 |
| Short return visit (20+ min) | 64 | $4,424 | $64 |
| New patient visit (45+ min) | 27 | $3,362 | $125 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 16 | $2,236 | $140 |
| New patient visit (30+ min) | 17 | $1,538 | $90 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 14 | $704 | $50 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $211 | $16 |
| Automated urinalysis test | 46 | $103 | $2 |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
330 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 11% · Women 66% · Also on Medicaid 22% · Health risk score 1.18. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 70% · Diabetes 31% · Chronic kidney disease 26% · Coronary heart disease 22% · Depression 20% · Heart failure 16% · Cancer 16% · Atrial fibrillation 15% · COPD 13% · Stroke 3%.
The office billed $150,754, Medicare allowed $56,815 and paid $39,601; for 543 services of 42 kinds; $40 of it was for drugs given in the office and $39,561 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 330 | 543 | 73 | 1.18 | $150,754 | $39,601 |
| 2023 | 373 | 533 | 73 | 1.07 | $133,143 | $38,437 |
| 2022 | 480 | 663 | 74 | 1.23 | $126,073 | $38,099 |
| 2021 | 400 | 501 | 72 | 1.31 | $99,590 | $32,269 |
| 2020 | 266 | 384 | 71 | 1.24 | $83,007 | $21,059 |
| 2019 | 412 | 635 | 73 | 1.19 | $130,558 | $33,478 |
| 2018 | 435 | 699 | 72 | 1.16 | $127,168 | $31,860 |
| 2017 | 225 | 316 | 71 | 1.26 | $55,768 | $13,227 |
| 2016 | 442 | 682 | 72 | 1.11 | $116,376 | $28,487 |
| 2015 | 188 | 272 | 71 | 1.22 | $50,172 | $14,356 |
| 2013 | 37 | 65 | 72 | 1.36 | $9,731 | $1,955 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 173 | $20,177 | $115 |
| Short return visit (20+ min) | 156 | $11,172 | $71 |
| New patient visit (45+ min) | 16 | $2,155 | $135 |
| New patient visit (30+ min) | 20 | $1,450 | $73 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 16 | $259 | $16 |
| Automated urinalysis test | 39 | $86 | $2 |
2022: 7 services
| Short return visit (20+ min) | 254 | $21,235 | $79 |
| New patient visit (30+ min) | 60 | $5,900 | $98 |
| Return visit (30+ min) | 56 | $5,815 | $104 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 102 | $2,243 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $194 | $13 |
| Automated urinalysis test | 44 | $102 | $2 |
| Urinalysis, manual test | 11 | $37 | $3 |
2021: 6 services
| Short return visit (20+ min) | 182 | $15,707 | $85 |
| Return visit (30+ min) | 64 | $7,662 | $120 |
| New patient visit (30+ min) | 49 | $4,029 | $82 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 96 | $2,267 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $144 | $10 |
| Automated urinalysis test | 25 | $59 | $2 |
2020: 4 services
| Short return visit (20+ min) | 122 | $8,021 | $63 |
| Return visit (30+ min) | 68 | $5,763 | $84 |
| New patient visit (30+ min) | 63 | $5,085 | $81 |
| Automated urinalysis test | 26 | $58 | $2 |
2019: 10 services
| Return visit (30+ min) | 124 | $11,575 | $89 |
| Short return visit (20+ min) | 167 | $10,711 | $61 |
| New patient visit (30+ min) | 50 | $4,182 | $84 |
| New patient visit (15+ min) | 70 | $3,351 | $48 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 19 | $308 | $16 |
| Detection test by immunoassay with direct visual observation for influenza virus | 12 | $211 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $182 | $12 |
| Injection of drug or substance under skin or into muscle | 11 | $148 | $13 |
| Automated urinalysis test | 51 | $128 | $2 |
| Urinalysis, manual test | 15 | $51 | $3 |
2018: 10 services
| Short return visit (20+ min) | 189 | $11,251 | $57 |
| Return visit (30+ min) | 94 | $8,578 | $90 |
| New patient visit (15+ min) | 136 | $6,988 | $51 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 23 | $373 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 14 | $285 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $237 | $14 |
| Injection of drug or substance under skin or into muscle | 11 | $196 | $16 |
| Automated urinalysis test | 53 | $150 | $3 |
| Urinalysis, manual test | 16 | $55 | $3 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 15 | $3 | None |
2017: 6 services
| Short return visit (20+ min) | 122 | $5,884 | $45 |
| New patient visit (15+ min) | 63 | $3,902 | $62 |
| Return visit (30+ min) | 31 | $2,485 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $216 | $14 |
| Automated urinalysis test | 21 | $63 | $3 |
| Urinalysis, manual test | 11 | $38 | $3 |
2016: 9 services
| Short return visit (20+ min) | 312 | $17,408 | $54 |
| Return visit (30+ min) | 62 | $5,038 | $81 |
| New patient visit (15+ min) | 36 | $1,486 | $41 |
| Short return visit | 22 | $679 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $390 | $13 |
| Injection of drug or substance under skin or into muscle | 13 | $311 | $24 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 21 | $260 | $12 |
| Urinalysis, manual test | 31 | $106 | $3 |
| Automated urinalysis test | 24 | $76 | $3 |
2015: 6 services
| Short return visit (20+ min) | 106 | $6,697 | $61 |
| Return visit (30+ min) | 45 | $4,234 | $92 |
| New patient visit (15+ min) | 23 | $1,407 | $61 |
| New patient visit (30+ min) | 11 | $1,055 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $170 | $15 |
| Urinalysis, manual test | 27 | $92 | $3 |
2013: 2 services
| Return visit (30+ min) | 19 | $1,123 | $59 |
| Short return visit (20+ min) | 16 | $626 | $39 |
Medicaid work
$2,520 in 2024
Medicaid paid $2,520 for 46 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Global fee urgent care centers | 30 | $2,482 |
| Return visit (30+ min) | 16 | $38 |
| 2024 | 46 | 2 | 18 | $2,520 |
| 2022 | 20 | 1 | 20 | $77 |
| 2021 | 36 | 1 | 18 | $196 |
See the largest Medicaid services in earlier years
2022
| OFF/OP EST MAY X REQ PHY/QHP | 20 | $77 |
2021
| OFF/OP EST MAY X REQ PHY/QHP | 36 | $196 |
Drugs they prescribed that Part D paid
$4,587
Pharmacies billed $4,587 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
271 generic and fewer than 11 brand-name prescriptions · $4,587 in drug cost · 156 antibiotic prescriptions to 140 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Paxlovid | 11 | $1,429 | $130 |
| Albuterol Sulfate Hfa | 14 | $387 | $28 |
| Cephalexin | 42 | $209 | $5 |
| Amoxicillin-Clavulanate Potass | 26 | $203 | $8 |
| Azithromycin | 27 | $178 | $7 |
See all 8 drugs
| Paxlovid | 11 | $1,429 | $130 |
| Albuterol Sulfate Hfa | 14 | $387 | $28 |
| Cephalexin | 42 | $209 | $5 |
| Amoxicillin-Clavulanate Potass | 26 | $203 | $8 |
| Azithromycin | 27 | $178 | $7 |
| Doxycycline Hyclate | 13 | $92 | $7 |
| Prednisone | 15 | $43 | $3 |
| Sulfamethoxazole-Trimethoprim | 20 | $43 | $2 |
Year by year
| 2024 | 307 | 227 | None | None | $4,587 |
| 2023 | 258 | 196 | None | None | $5,361 |
| 2022 | 219 | 169 | None | 5% | $3,118 |
| 2021 | 196 | 155 | 7% (13) | 6% | $3,468 |
| 2020 | 161 | 122 | None | 11% | $4,243 |
| 2019 | 256 | 197 | 4% (11) | 13% | $5,442 |
| 2018 | 321 | 244 | 7% (21) | 10% | $5,575 |
| 2017 | 180 | 116 | None | 13% | $4,127 |
| 2016 | 367 | 235 | 7% (25) | 13% | $10,796 |
| 2015 | 260 | 148 | 6% (15) | 8% | $3,999 |
| 2014 | 441 | 81 | 6% (28) | None | $25,351 |
| 2013 | 225 | 81 | 12% (27) | None | $11,812 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Albuterol Sulfate Hfa | 14 | $380 | $27 |
| Cephalexin | 31 | $195 | $6 |
| Amoxicillin-Clavulanate Potass | 20 | $151 | $8 |
| Sulfamethoxazole-Trimethoprim | 17 | $75 | $4 |
| Azithromycin | 17 | $66 | $4 |
| Prednisone | 19 | $47 | $2 |
2022: 5 drugs
| Amoxicillin-Clavulanate Potass | 20 | $307 | $15 |
| Cephalexin | 25 | $200 | $8 |
| Paxlovid (Eua) | 11 | $105 | $10 |
| Sulfamethoxazole-Trimethoprim | 12 | $46 | $4 |
| Prednisone | 11 | $46 | $4 |
2021: 2 drugs
| Cephalexin | 32 | $176 | $6 |
| Sulfamethoxazole-Trimethoprim | 16 | $53 | $3 |
2020: 2 drugs
| Cephalexin | 17 | $79 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $46 | $4 |
2019: 4 drugs
| Ventolin Hfa | 12 | $693 | $58 |
| Azithromycin | 33 | $293 | $9 |
| Cephalexin | 35 | $250 | $7 |
| Prednisone | 11 | $28 | $3 |
2018: 7 drugs
| Cephalexin | 46 | $297 | $6 |
| Azithromycin | 39 | $245 | $6 |
| Levofloxacin | 16 | $167 | $10 |
| Amoxicillin-Clavulanate Potass | 15 | $145 | $10 |
| Ciprofloxacin | 16 | $85 | $5 |
| Prednisone | 18 | $69 | $4 |
| Hydrocodone-Acetaminophen | 14 | $69 | $5 |
2017: 3 drugs
| Azithromycin | 21 | $165 | $8 |
| Amoxicillin-Clavulanate Potass | 12 | $114 | $9 |
| Prednisone | 12 | $52 | $4 |
2016: 8 drugs
| Proair Hfa | 12 | $643 | $54 |
| Ventolin Hfa | 11 | $572 | $52 |
| Azithromycin | 50 | $397 | $8 |
| Amoxicillin-Clavulanate Potass | 16 | $200 | $13 |
| Ciprofloxacin | 20 | $171 | $9 |
| Cephalexin | 25 | $134 | $5 |
| Hydrocodone-Acetaminophen | 11 | $89 | $8 |
| Prednisone | 13 | $56 | $4 |
2015: 5 drugs
| Azithromycin | 18 | $112 | $6 |
| Lisinopril | 14 | $109 | $8 |
| Metformin | 11 | $95 | $9 |
| Cephalexin | 15 | $95 | $6 |
| Ciprofloxacin | 14 | $65 | $5 |
2014: 11 drugs
| Diovan | 14 | $3,589 | $256 |
| Levemir | 12 | $2,538 | $211 |
| Metoprolol | 15 | $687 | $46 |
| Atorvastatin | 19 | $277 | $15 |
| Hydrocodone-Acetaminophen | 15 | $201 | $13 |
| Lisinopril | 25 | $185 | $7 |
| Simvastatin | 13 | $172 | $13 |
| Omeprazole | 11 | $143 | $13 |
| Metformin | 20 | $136 | $7 |
| Hydrochlorothiazide | 14 | $127 | $9 |
| Furosemide | 13 | $77 | $6 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 14 | $134 | $10 |
| Lisinopril | 13 | $74 | $6 |
Professional record
- NPI
- 1649433178
- Licence
- CA A104778California A104778: Current · expires 2028-04-30
- Trained
- Tulane University School of Medicine, 2006
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 255228, Sacramento, CA, 95865
- NPI first listed
- 2008-07-03
- NPI last updated
- 2024-08-08
- NPI record certified
- 2024-08-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4053 Lone Tree Way, Antioch, CA, 94531 · 2500 Milvia St, Berkeley, CA, 94704 · 20101 Lake Chabot Rd Fl 1, Castro Valley, CA, 94546 · 2700 Grant St, Concord, CA, 94520